StockData
NeoGenomics Inc logo

NeoGenomics Inc (NEO) income statement

NEONasdaqServices-Testing LaboratoriesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 11/3025% below fair value
$15.29+0.04 (+0.26%)

Close on Nov 18, 2026Market cap $1.98BP/E –Yield –

NeoGenomics Inc income statement

Ratios

Latest available, balances at Sep 30, 2026

Profitability, TTM

Gross margin
44.8%
Operating margin
-6.3%
Net margin
-4.1%
Return on equity, FY2025
-12.4%

Financial strength

Current ratio
3.53
Debt to equity
0.47
Debt to assets
27.2%
Cash to current liabilities
119.9%

Valuation

P/E ratio
–
Price to sales
2.51
Price to book
2.47
Dividend yield
–

See a number that looks wrong?